We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XWhite Paper
August 29, 2014
Reductions in the cost and duration of early-phase trials can ease patient recruitment and
improve clinical accuracy. However, as Dmitri Petratchenko of Valos explains, successful
implementation of adaptive designs into a trial requires unparalleled coordination between
clinicians, trial managers, statisticians and regulators.
Download to find out more.